Article Text

Download PDFPDF
Spontaneous coronary artery dissection: to do good or to do no harm?
  1. Philip D Adamson1,2
  1. 1 Christchurch Heart Institute, University of Otago Christchurch, Christchurch, New Zealand
  2. 2 BHF Centre for Cardiovascular Science, University of Edinburgh, Edinburgh, UK
  1. Correspondence to Dr Philip D Adamson, Christchurch Heart Institute, University of Otago Christchurch, PO Box 4345, Christchurch 8140, New Zealand; Philip.adamson{at}cdhb.health.nz

Statistics from Altmetric.com

‘First, do no harm’ are oft misquoted words from Hippocrates’ 2500-year-old work Epidemics. A more complete and accurate translation of his exhortation reads:

The physician must be able to tell the antecedents, know the present, and foretell the future — must mediate these things, and have two special objects in view with regard to disease, namely, to do good or to do no harm.1

This is laudable sentiment but is it realistic for a diagnosis surrounding which much uncertainty remains?

Looking back only 20 years, a case report in this publication described spontaneous coronary artery dissection (SCAD) as ‘an extremely rare cause of unstable angina and acute myocardial infarction’.2 That is no longer the case. There has been a surge in the recognition of the condition. One recent study found 33 (2.4%) cases of SCAD among 1375 patients who underwent invasive coronary angiography for acute coronary syndrome in 2019.3 This represents a 10-fold increase in relative diagnostic frequency since an earlier registry (1999–2007) identified only 22 (0.2%) cases from 11 175 patients.4 Presuming that the true incidence is unchanged, this growth reflects a remarkable ‘paradigm shift in clinical appreciation’.5

The challenge we face

In contrast to many cardiovascular disorders, SCAD is predominantly a disease affecting middle-aged women with comparatively few traditional atherosclerotic risk factors. The epidemiology, pathophysiology and approach to diagnosis of SCAD have been informed by retrospective observational cohort studies but optimal management remains unclear. Invasive coronary angiography represents the primary imaging modality for identifying the condition, meaning definitive treatment decisions are commonly made in the catheter laboratory and herein lies the challenge. In contrast with atherosclerotic disease, percutaneous coronary intervention (PCI) is associated with less predictable outcomes in …

View Full Text

Footnotes

  • Contributors PDA wrote the editorial and commissioned the figure.

  • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

  • Competing interests None declared.

  • Patient and public involvement Patients and/or the public were not involved in the design, or conduct, or reporting, or dissemination plans of this research.

  • Provenance and peer review Commissioned; internally peer reviewed.

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Linked Articles

  • Coronary artery disease
    Deevia Kotecha Marcos Garcia-Guimaraes Diluka Premawardhana Dario Pellegrini Clare Oliver-Williams Vasiliki Bountziouka Alice Wood Nalin Natarajan Robert Jackson Nathan Chan Jan Ziaullah Roby D Rakhit Stephen P Hoole Tom W Johnson Jacek Kadziela Peter Ludman Nilesh J Samani Angela H E M Maas Robert-Jan van Geuns Fernando Alfonso David Adlam